Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Allergan acquires regenerative medicine company LifeCell

Executive Summary

Allergan PLC acquired Acelity LP Inc.'s LifeCell Corp. business (regenerative medicine) for $2.9bn in cash in one of the largest device M&A deals of 2016. The transaction is expected to add $450mm in 2016 projected revenues with 75% gross margin and 40% operating margin.
Deal Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash
    • Acquisition of Private Biotech

Related Companies

Advertisement
UsernamePublicRestriction

Register